Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 136

1.

Decreased circulating miRNA levels in patients with primary progressive multiple sclerosis.

Fenoglio C, Ridolfi E, Cantoni C, De Riz M, Bonsi R, Serpente M, Villa C, Pietroboni AM, Naismith RT, Alvarez E, Parks BJ, Bresolin N, Cross AH, Piccio LM, Galimberti D, Scarpini E.

Mult Scler. 2013 Dec;19(14):1938-42. doi: 10.1177/1352458513485654.

PMID:
24277735
2.

Regulated microRNAs in the CSF of patients with multiple sclerosis: a case-control study.

Haghikia A, Haghikia A, Hellwig K, Baraniskin A, Holzmann A, Décard BF, Thum T, Gold R.

Neurology. 2012 Nov 27;79(22):2166-70. doi: 10.1212/WNL.0b013e3182759621. Epub 2012 Oct 17.

PMID:
23077021
3.

Differential microRNA expression in blood in multiple sclerosis.

Søndergaard HB, Hesse D, Krakauer M, Sørensen PS, Sellebjerg F.

Mult Scler. 2013 Dec;19(14):1849-57. doi: 10.1177/1352458513490542. Epub 2013 Jun 17.

PMID:
23773985
4.

miR-326 and miR-26a, two potential markers for diagnosis of relapse and remission phases in patient with relapsing-remitting multiple sclerosis.

Honardoost MA, Kiani-Esfahani A, Ghaedi K, Etemadifar M, Salehi M.

Gene. 2014 Jul 10;544(2):128-33. doi: 10.1016/j.gene.2014.04.069. Epub 2014 Apr 30.

PMID:
24792898
5.

Increased plasma 8,12-iso-iPF2alpha- VI levels in relapsing multiple sclerosis patients are not predictive of disease progression.

Teunissen CE, Sombekke M, van Winsen L, Killestein J, Barkhof F, Polman CH, Dijkstra CD, Blankenstein MA, Pratico D.

Mult Scler. 2012 Aug;18(8):1092-8. doi: 10.1177/1352458511433306. Epub 2012 Jun 13.

PMID:
22695538
6.

MicroRNA-572 expression in multiple sclerosis patients with different patterns of clinical progression.

Mancuso R, Hernis A, Agostini S, Rovaris M, Caputo D, Clerici M.

J Transl Med. 2015 May 7;13:148. doi: 10.1186/s12967-015-0504-2.

7.

Effect of fingolimod treatment on circulating miR-15b, miR23a and miR-223 levels in patients with multiple sclerosis.

Fenoglio C, De Riz M, Pietroboni AM, Calvi A, Serpente M, Cioffi SM, Arcaro M, Oldoni E, Scarpini E, Galimberti D.

J Neuroimmunol. 2016 Oct 15;299:81-83. doi: 10.1016/j.jneuroim.2016.08.017. Epub 2016 Aug 31.

PMID:
27725128
8.

Circulating microRNAs as biomarkers for disease staging in multiple sclerosis.

Gandhi R, Healy B, Gholipour T, Egorova S, Musallam A, Hussain MS, Nejad P, Patel B, Hei H, Khoury S, Quintana F, Kivisakk P, Chitnis T, Weiner HL.

Ann Neurol. 2013 Jun;73(6):729-40. doi: 10.1002/ana.23880. Epub 2013 Jul 8.

PMID:
23494648
9.

Protein biomarkers for multiple sclerosis: semi-quantitative analysis of cerebrospinal fluid candidate protein biomarkers in different forms of multiple sclerosis.

Avsar T, Korkmaz D, Tütüncü M, Demirci NO, Saip S, Kamasak M, Siva A, Turanli ET.

Mult Scler. 2012 Aug;18(8):1081-91. doi: 10.1177/1352458511433303. Epub 2012 Jan 17.

PMID:
22252467
10.
11.

An investigation of susceptibility loci in benign, aggressive and primary progressive multiple sclerosis in Northern Irish population.

Gray OM, Abdeen H, McDonnell GV, Patterson CC, Graham CA, Hawkins SA.

Mult Scler. 2009 Mar;15(3):299-303. doi: 10.1177/1352458508099611.

PMID:
19244395
12.

Hypointense lesions on T1-weighted spin-echo magnetic resonance imaging: relation to clinical characteristics in subgroups of patients with multiple sclerosis.

van Walderveen MA, Lycklama A Nijeholt GJ, Adèr HJ, Jongen PJ, Polman CH, Castelijns JA, Barkhof F.

Arch Neurol. 2001 Jan;58(1):76-81.

PMID:
11176939
13.

Multiple sclerosis: microRNA expression profiles accurately differentiate patients with relapsing-remitting disease from healthy controls.

Keller A, Leidinger P, Lange J, Borries A, Schroers H, Scheffler M, Lenhof HP, Ruprecht K, Meese E.

PLoS One. 2009 Oct 13;4(10):e7440. doi: 10.1371/journal.pone.0007440.

14.

Complement regulator factor H as a serum biomarker of multiple sclerosis disease state.

Ingram G, Hakobyan S, Hirst CL, Harris CL, Pickersgill TP, Cossburn MD, Loveless S, Robertson NP, Morgan BP.

Brain. 2010 Jun;133(Pt 6):1602-11. doi: 10.1093/brain/awq085. Epub 2010 Apr 25.

PMID:
20421219
15.

Brain atrophy in relapsing-remitting multiple sclerosis and secondary progressive multiple sclerosis: longitudinal quantitative analysis.

Ge Y, Grossman RI, Udupa JK, Wei L, Mannon LJ, Polansky M, Kolson DL.

Radiology. 2000 Mar;214(3):665-70.

PMID:
10715027
16.

Serum anti-GAGA4 IgM antibodies differentiate relapsing remitting and secondary progressive multiple sclerosis from primary progressive multiple sclerosis and other neurological diseases.

Brettschneider J, Jaskowski TD, Tumani H, Abdul S, Husebye D, Seraj H, Hill HR, Fire E, Spector L, Yarden J, Dotan N, Rose JW.

J Neuroimmunol. 2009 Dec 10;217(1-2):95-101. doi: 10.1016/j.jneuroim.2009.07.017. Epub 2009 Oct 30.

PMID:
19879655
17.

Progranulin genetic polymorphisms influence progression of disability and relapse recovery in multiple sclerosis.

Vercellino M, Fenoglio C, Galimberti D, Mattioda A, Chiavazza C, Binello E, Pinessi L, Giobbe D, Scarpini E, Cavalla P.

Mult Scler. 2016 Jul;22(8):1007-12. doi: 10.1177/1352458515610646. Epub 2015 Oct 7.

PMID:
26447062
18.

Increase in CCR5 Delta32/Delta32 genotype in multiple sclerosis.

Pulkkinen K, Luomala M, Kuusisto H, Lehtimäki T, Saarela M, Jalonen TO, Elovaara I.

Acta Neurol Scand. 2004 May;109(5):342-7.

PMID:
15080861
19.

The cannabinoid receptor 1 gene (CNR1) and multiple sclerosis: an association study in two case-control groups from Spain.

Ramil E, Sánchez AJ, González-Pérez P, Rodríguez-Antigüedad A, Gómez-Lozano N, Ortiz P, Arroyo R, De las Heras V, Vilches C, García-Merino A.

Mult Scler. 2010 Feb;16(2):139-46. doi: 10.1177/1352458509355071. Epub 2009 Dec 9.

PMID:
20007426
20.

Expression and genetic analysis of miRNAs involved in CD4+ cell activation in patients with multiple sclerosis.

Fenoglio C, Cantoni C, De Riz M, Ridolfi E, Cortini F, Serpente M, Villa C, Comi C, Monaco F, Mellesi L, Valzelli S, Bresolin N, Galimberti D, Scarpini E.

Neurosci Lett. 2011 Oct 17;504(1):9-12. doi: 10.1016/j.neulet.2011.08.021. Epub 2011 Aug 19.

PMID:
21875645

Supplemental Content

Support Center